Inventor · disambiguated record
Lloyd B. Klickstein
Also filed as: KLICKSTEIN LLOYD · KLICKSTEIN LLOYD B · KLICKSTEIN LLOYD BERL
13 granted patents·10 pending applications·417 citations·filing 1989–2024
93Inventor score
Top patents by PatentIndex Score
23 records- 0192US5212071ANucleic acids encoding a human C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1989·Granted May 18, 1993·100 cites·64 claims
- 0290US5472939AMethod of treating complement mediated disordersUNIV JOHNS HOPKINS·Filed 1993·Granted Dec 5, 1995·70 cites·37 claims
- 0389US5981481AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Nov 9, 1999·80 cites·42 claims
- 0486US5856297AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Jan 5, 1999·58 cites·14 claims
- 0586US5256642ACompositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereofUNIV JOHNS HOPKINS·Filed 1990·Granted Oct 26, 1993·49 cites·13 claims
- 0683US10064844B2Pharmaceutical compositions comprising an aromatse inhibitorsMEREO BIOPHARMA 2 LTD·Filed 2016·Granted Sep 4, 2018·2 cites·17 claims
- 0780US6316604B1Human C3b/C4b receptor (CR1)AVANT IMMUNOTHERAPEUTICS INC·Filed 1995·Granted Nov 13, 2001·46 cites·14 claims
- 0876US9295668B2Use of an aromatase inhibitor for the treatment of hypogonadism and related diseasesTAYLOR ANN·Filed 2012·Granted Mar 29, 2016·3 cites·21 claims
- 0976US9296826B2Antibodies and methods for WNT pathway-related diseasesCONG FENG·Filed 2012·Granted Mar 29, 2016·5 cites·10 claims
- 1074US11357851B2Uses of myostatin antagonists, combinations containing them and uses thereofNOVARTIS AG·Filed 2016·Granted Jun 14, 2022·2 cites·11 claims
- 1170US9750724B2Use of an aromatase inhibitor for the treatment of hypogonadism and related diseasesMEREO BIOPHARMA 2 LTD·Filed 2016·Granted Sep 5, 2017·1 cites·21 claims
- 1268US9370505B2Pharmaceutical compositions comprising an aromatse inhibitorsTAYLOR ANN·Filed 2012·Granted Jun 21, 2016·1 cites·17 claims
- 1366US2024368291A1Actrii antibody treatmentsVERSANIS BIO INC·Filed 2024·Application pending·0 cites
- 1466US2024002843A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1565US2024325530A1Combination therapiesVERSANIS BIO INC·Filed 2024·Application pending·0 cites
- 1661US2022265823A1Uses of myostatin antagonists, combinations containing them and uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1749US11179364B2Licofligozin for the treatment of non-alcoholic steatohepatitisNOVARTIS AG·Filed 2018·Granted Nov 23, 2021·0 cites·8 claims
- 1848US2009175875A1Molecules and Methods for Modulating Complement ComponentNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1946US2019083473A1Azabicyclooctane derivatives as fxr agonists for use in the treatment of liver and gastrointestinal diseasesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2042US2019010495A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2016·Application pending·0 cites
- 2139US2018066067A1Antibodies and methods for wnt pathway-related diseasesCONG FENG·Filed 2016·Application pending·0 cites
- 2238US2019192485A1Dosage regimen for the treatment of endometriosisMEREO BIOPHARMA 2 LTD·Filed 2017·Application pending·0 cites
- 2329US2017260275A1Myostatin or activin antagonists for the treatment of sarcopeniaNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lloyd B. Klickstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →